Advertisement

Topics

Zai Lab raises $30mm in Series C round

15:40 EDT 30 Jun 2017 | Elsevier Business Intelligence

Zai Lab Ltd. (Chinese biopharmaceutical company) raised $30mm in its Series C financing round. The round was led by OrbiMed ...

Original Article: Zai Lab raises $30mm in Series C round

NEXT ARTICLE

More From BioPortfolio on "Zai Lab raises $30mm in Series C round"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...